2013/14

PUBLIC HEALTH SERVICES CONTRACT

APPENDIX A

SERVICE SPECIFICATIONS

All subheadings for local determination and agreement.

Service Specification No.
Service / Dispensing Champix under a PGD
Authority Lead / Pat Nicholl
Provider Lead
Period / 1st April 2013- 31st March 2014
Date of Review
1. Population Needs
1.1 National/local context and evidence base
Smoking remains the leading cause of preventable death and disease in England, and is one of the most significant factors that impact on health inequalities and ill health, particularly cancer, coronary heart disease and respiratory disease. Reducing smoking prevalence therefore remains a key public health priority in reducing health inequalities and improving health among local populations.
Reducing the number of people who smoke is a public health priority. Smoking is implicated in around 70% of all deaths and is a significant causal factor in preventable deaths amongst local residents. The Sefton Lifestyle Survey 2010 indicated that in the most deprived neighbourhoods in Sefton as many as 30% of the population smokes. This places a significant burden on the health of the most deprived population and is the leading cause of health inequalities and reduced life expectancy in Sefton. It is our aim to increase the number of smokers making a quit attempt by offering choice, removing barriers and encouraging smokers to move along the cycle of change. One of the strategies used to achieve this will be via the community pharmacy setting.
Since stop smoking services began they have supported over 2.5 million people to stop in the short term and 625,000 people to stop in the long term, saving over 70,000 lives. SUPPORT established in 2000 has helped to achieve nearly 30,000 successful quits. Since their inception stop smoking service through effective working with local pharmacies has become well established, delivering substantial numbers of four week quitters each year and around a quarter of all successful quits per year. This is why it remains a key outcome in the Public Health Outcomes Framework 2013/14
Evidence-based stop smoking support is highly effective both in cost and clinical terms. It should therefore be seen in the same way as any other clinical service and offered to all smokers.
Community pharmacies are easily accessible: 99% of the population, even those living in the most deprived areas, can get to a pharmacy within 20 minutes by walking or using public transport. Some 84% of adults visit a pharmacy at least once a year. An estimated 1.6 million visits take place daily. This ready access makes community pharmacies an ideal location to provide advice and support for those who want to stop smoking and to dispense Nicotine Replacement Therapy products and support stop smoking services.
In March 2011 Department of Health published a new Tobacco Control Plan, which outlined the Governments key priorities, action and ambitions for tobacco control in England over the forthcoming five years.
2. Key Service Outcomes
2.1 Insert any locally agreed outcomes and quality requirements which are NOT Quality
Outcomes Indicators which should be set out in Appendix C (Quality Outcomes Indicators)
The service will ultimately contribute towards the following objectives within the Public Health Outcomes Framework
People are helped to live healthy lifestyles, make healthy choices and reduce health inequalities
Reduced numbers of people living with preventable ill health and people dying prematurely, while reducing the gap between communities
Service outcomes
To improve access to and choice of stop smoking services, including access to pharmacological stop smoking aids
To assist in the delivery of Public Health Outcomes Framework and National Tobacco Control Plan
To reduce smoking related illnesses and deaths by helping people to give up smoking
To improve the health of the population by reducing exposure to passive smoke
The pharmacy has appropriate NHS provided health promotion material available for potential clients and promotes the uptake of the stop smoking service
The pharmacy supports the Stop Smoking Service in updating its standard operating procedures on an two yearly basis
3. Scope
3.1 Aims and objectives of service
The purpose of this Service Level Agreement is to enable easy and equitable access to Champix. The aim is that through ease of access to appropriate stop smoking treatments this service will contribute towards a reduction in smoking prevalence across Sefton by supporting high quality stop smoking service provision.
Objectives:
  • Keep up to date with current Patient Group Direction, protocols and procedures
  • Follow the PGD
  • Identify and communicate operational challenges to the LCH and Sefton Council
  • Link with NHS and Council stop smoking campaigns delivered nationally and locally
3.2 Service description/pathway
1. Service Delivery
2. Records
3. Training
4. Quality Indicators
Criterion One : Service Delivery
Details
• The pharmacy contractor will ensure that all staff involved in the provision of the service are aware of and act in accordance with the PGD (see appendix 1).
• The pharmacy contractor will supply Vareniclinedirectly to the service user in accordance with the PGD issued and authorised by Liverpool Community Health NHS Trust and will advise on its use.
• Should the pharmacy contractor have any concerns about the appropriateness of therecommended therapy or the validity of the letter supplied by the stop smoking service SUPPORT they will discuss this with the appropriate member of the authorised stop smoking services team before making a supply and agree a course of action.
Criterion Two: Records
Details
• The council will provide a framework (Webstar database system) for the recording of relevant service information for the purposes of audit and the claiming of payment. Where data is missing or unclear then claims for payment will be returned to the pharmacy for clarification and re-submission.
• Claims for payment will be submitted monthly through the webstar reporting system
• The pharmacy contractor should ensure that the staff who currently (or may in the future)
complete claim forms are fully aware of the necessity to follow the correct procedures with
regards to patient data protection.
Criterion Three: Training
Details
• The pharmacy contractor will ensure that pharmacists involved in the provision of the service have received the relevant training as detailed within the PGD and are appropriately trained in the operation of the service
Criterion Five : Quality Indicators
Details
• The pharmacy contractor has appropriate council/stop smoking service provided health promotion material available for the stop smoking service and promotes its uptake.
• The pharmacy contractor has a copy of the PGDand reviews the implementation within their organisation on an annual basis.
• The pharmacy contractor can demonstrate that all staff involved in the provision of the service has undertaken training as stated in the PGD as well as CPD relevant to this service.
• The pharmacy contractor participates in any council organised audit of service provision.
• The pharmacy contractor co-operates with any locally agreed council-led assessment of service user experience.As a minimum reporting any complaints and compliments received by service users.
ONGOING MEASUREMENT AND EVALUATION
1. The pharmacy contractor is required to agree with the council this service specification/plan.
2. The specific data measurement, evaluation and audit requirements of the scheme are
outlined in the individual sections of this document
3. The pharmacy contractor will be required to collate the necessary evidence of compliancewith the requirements of the scheme.
4. The scheme will then be evaluated as part of an annual contract review
3.3 Population covered
Those eligible for this service are:
Smokers aged over 18 years of agewho are attending the specialist stop smoking service, who live in Sefton, work in Sefton or who attend college within Sefton
3.4 Any acceptance and exclusion criteria and thresholds
The community pharmacy will comply with all the requirements of the essential services ofthe NHS Community Pharmacy Contractual Framework.
• The community pharmacy will ensure that pharmacists are appropriately trained in line with the PGD and thus competent to provide product advice.
• The community pharmacy will ensure that any paperwork relating to the service, local procedures and guidelines issued by the Council are easily accessible in the pharmacy.
• The community pharmacy may be required to undertake clinical audits relating to theservice where required by the council. For clarification, this is additional to audits required under the national pharmacy contract.
3.5 Interdependencies with other services
This service cannot be delivered in isolation it must be considered in partnership with a range of other providers and organisations including:
  • Sefton SUPPORT provided by Liverpool Community Health Service ensures that quality and performance is managed on behalf of the commissioner. Liverpool Community Health have a quality, training and support responsibility for the PGD
  • Sefton MBC
  • Service users
  • South Sefton and Southport and Formby CCG’s
Healthy Sefton provides a single point of access to healthy lifestyle services and can sign post to local pharmacy services. Information on the times of access of smoking cessation services should be provided to SUPPORT who can ensure that the service is listed on the Healthy Sefton telephone script.
3.6 Any activity planning assumptions
4. Applicable Service Standards
4.1 Applicable national standards egNICE
The service provider must be in line with relevant evidence and guidance notably:
NICE -TA123 Varenicline for smoking cessation
Department of Health Local Stop Smoking Services delivery and monitoring guidance 2011/12.
NICE -Guidance PH01 Brief interventions and referral for smoking cessation
NICE- Guidance PH10 Smoking Cessation Services
4.2 Applicable local standard
Liverpool Community Health Patient Group Direction for the administration of Varenicline
Sefton SUPPORT Treatment Protocol. Clinical Practice Procedure.
Fagerstrom Tolerance Test, Initial assessment procedure
Risk management
The contractor will have in place robust systems for the identification and management of clinical and non-clinical risk
5. Location of Provider Premises
The Provider’s Premises are located at:
[Insert address of Provider’s Premises if applicable]
Payment
The community pharmacy will be reimbursed at cost price +VAT for Champix supplied along with a supply payment at £5.80 each
• Payment to community pharmacies will be managed and administered by Sefton council
organisation.

FINAL –PUBLIC HEALTH SERVICES CONTRACT

GATEWAY REFERENCE: 18533